Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.510
-0.030 (-1.95%)
Aug 14, 2025, 11:33 AM - Market open
Pulmonx Stock Forecast
LUNG's stock price has decreased by -73.49% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 7 professional analysts, the 12-month price target for Pulmonx stock ranges from a low of $2.50 to a high of $16. The average analyst price target of $7.66 forecasts a 407.28% increase in the stock price over the next year.
Price Target: $7.66 (+407.28%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Pulmonx stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
Buy | 1 | 1 | 1 | 1 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Wells Fargo | Wells Fargo | Hold Maintains $6 → $3 | Hold | Maintains | $6 → $3 | +98.68% | Aug 1, 2025 |
Lake Street | Lake Street | Strong Buy Maintains $12 → $8 | Strong Buy | Maintains | $12 → $8 | +429.80% | Jul 31, 2025 |
Stifel | Stifel | Strong Buy Maintains $16 → $5 | Strong Buy | Maintains | $16 → $5 | +231.13% | Jul 31, 2025 |
Piper Sandler | Piper Sandler | Buy → Hold Downgrades $9 → $2.5 | Buy → Hold | Downgrades | $9 → $2.5 | +65.56% | Jul 31, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $17 → $16 | Strong Buy | Maintains | $17 → $16 | +959.60% | Jul 31, 2025 |
Financial Forecast
Revenue This Year
98.80M
from 83.79M
Increased by 17.92%
Revenue Next Year
117.14M
from 98.80M
Increased by 18.56%
EPS This Year
-1.56
from -1.44
EPS Next Year
-1.44
from -1.56
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 102.3M | 124.2M | 186.6M | ||
Avg | 98.8M | 117.1M | 147.4M | ||
Low | 93.6M | 108.2M | 127.3M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 22.0% | 25.7% | 59.3% | ||
Avg | 17.9% | 18.6% | 25.8% | ||
Low | 11.7% | 9.5% | 8.7% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -1.56 | -1.24 | -0.90 | ||
Avg | -1.56 | -1.44 | -1.21 | ||
Low | -1.55 | -1.52 | -1.43 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.